JP2021518372A5 - - Google Patents
Info
- Publication number
- JP2021518372A5 JP2021518372A5 JP2020550071A JP2020550071A JP2021518372A5 JP 2021518372 A5 JP2021518372 A5 JP 2021518372A5 JP 2020550071 A JP2020550071 A JP 2020550071A JP 2020550071 A JP2020550071 A JP 2020550071A JP 2021518372 A5 JP2021518372 A5 JP 2021518372A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- pharmaceutical composition
- composition according
- i2fa
- subject
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862646901P | 2018-03-22 | 2018-03-22 | |
| US62/646,901 | 2018-03-22 | ||
| PCT/US2019/023463 WO2019183417A1 (en) | 2018-03-22 | 2019-03-21 | Modified oligonucleotides and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021518372A JP2021518372A (ja) | 2021-08-02 |
| JP2021518372A5 true JP2021518372A5 (https=) | 2022-03-25 |
| JPWO2019183417A5 JPWO2019183417A5 (https=) | 2022-03-25 |
Family
ID=66223809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550071A Pending JP2021518372A (ja) | 2018-03-22 | 2019-03-21 | 修飾オリゴヌクレオチド及び使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210015884A1 (https=) |
| EP (1) | EP3768840A1 (https=) |
| JP (1) | JP2021518372A (https=) |
| CN (1) | CN112166191A (https=) |
| CA (1) | CA3094508A1 (https=) |
| MA (1) | MA52132A (https=) |
| WO (1) | WO2019183417A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022013420A1 (en) * | 2020-07-17 | 2022-01-20 | European Molecular Biology Laboratory | Prognostic biomarkers for cancer |
| CN116555325A (zh) * | 2023-04-11 | 2023-08-08 | 内蒙古农业大学 | 本氏烟m6A甲基化酶基因在抗病毒中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017075451A1 (en) * | 2015-10-28 | 2017-05-04 | The Broad Institute Inc. | Compositions and methods for evaluating and modulating immune responses by detecting and targeting pou2af1 |
| CN107349217B (zh) * | 2017-07-21 | 2020-06-09 | 深圳大学 | 一种基于mettl3的小干扰rna及其药物和应用 |
-
2019
- 2019-03-21 WO PCT/US2019/023463 patent/WO2019183417A1/en not_active Ceased
- 2019-03-21 JP JP2020550071A patent/JP2021518372A/ja active Pending
- 2019-03-21 EP EP19718493.0A patent/EP3768840A1/en not_active Withdrawn
- 2019-03-21 CA CA3094508A patent/CA3094508A1/en active Pending
- 2019-03-21 CN CN201980034104.5A patent/CN112166191A/zh active Pending
- 2019-03-21 MA MA052132A patent/MA52132A/fr unknown
- 2019-03-21 US US17/040,029 patent/US20210015884A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018126141A5 (https=) | ||
| JP2019088329A5 (https=) | ||
| JP2021512629A5 (https=) | ||
| JP2020522244A5 (https=) | ||
| JP2006515277A5 (https=) | ||
| HRP20241138T1 (hr) | Oligonukleotidi za induciranje ekspresije očinskog ube3a | |
| JP2019068829A5 (https=) | ||
| JP2016501513A5 (https=) | ||
| JP2018150344A5 (https=) | ||
| JP2018523668A5 (https=) | ||
| JP2017513469A5 (https=) | ||
| JP2016502858A5 (https=) | ||
| WO2009109665A4 (en) | Pharmaceutical compositions for treatment of microrna related diseases | |
| JP2003520811A5 (https=) | ||
| HRP20210315T1 (hr) | Oligonukleotidi za smanjenje ekspresije pd-l1 | |
| JP2014511686A5 (https=) | ||
| JP2017070307A5 (https=) | ||
| JP2016523548A5 (https=) | ||
| JP2009511034A5 (https=) | ||
| CA2520541A1 (en) | Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field | |
| JP2008523157A5 (https=) | ||
| JP2012510297A5 (https=) | ||
| JP2009508527A5 (https=) | ||
| JP2022501024A5 (https=) | ||
| JP2021500016A5 (https=) |